NIH-funded study suggests immune cells rush through channels to get to injured tissue quickly
The jury is still out on whether people at moderate risk of a first heart attack or stroke should take daily aspirin to lower their risk
CURRENT ISSUE - January/February 2026
Applying the Six Cs Helps Labs Deliver Results Stakeholders Can Rely On